Article Versions Notes

Luongo C, Porcelli T, Sessa F, De Stefano MA, Scavuzzo F, Damiano V, Klain M, Bellevicine C, Matano E, Troncone G, et al. Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report. Current Oncology. 2021; 28(6):5401-5407. https://doi.org/10.3390/curroncol28060450

Luongo, Cristina, Tommaso Porcelli, Francesca Sessa, Maria Angela De Stefano, Francesco Scavuzzo, Vincenzo Damiano, Michele Klain, Claudio Bellevicine, Elide Matano, Giancarlo Troncone, and et al. 2021. "Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report" Current Oncology 28, no. 6: 5401-5407. https://doi.org/10.3390/curroncol28060450

Luongo, C., Porcelli, T., Sessa, F., De Stefano, M. A., Scavuzzo, F., Damiano, V., Klain, M., Bellevicine, C., Matano, E., Troncone, G., Schlumberger, M., & Salvatore, D. (2021). Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report. Current Oncology, 28(6), 5401-5407. https://doi.org/10.3390/curroncol28060450